Vajargah KK, Dib MJ, Tavolinejad H, Zamani P, Richards AM, Mann DL, Rietzschel E, van Empel V, Burgess S, Cappola TP, Chirinos JA. Proteome-Wide Genetic Investigation of Kidney Function in Heart Failure With Preserved Ejection Fraction , JACC Heart Fail: 2025,102771

Saw EL, Werner LD, Cooper H, Pimental DR, Zamani P, Chirinos JA, Valero-Muñoz M, Sam F. Musclin Counteracts Skeletal Muscle Dysfunction and Exercise Intolerance in Heart Failure With Preserved Ejection Fraction , Circ Heart Fail, 18(6): 2025,e012350

Selvaraj S, Karaj A, Chirinos JA, Denney N, Grosso G, Fernando M, Chambers K, Demastus C, Reddy R, Langham M, Kumar D, Maynard H, Pourmussa B, Prenner SB, Cohen JB, Ischiropoulos H, Rickels MR, Poole DC, Church DD, Wolfe RR, Kelly DP, Putt M, Margulies KB, Zamani P Crossover Trial of Exogenous Ketones on Cardiometabolic Endpoints in Heart Failure with Preserved Ejection Fraction , JACC Heart Fail, 13(12): 2025,102435

Selvaraj S; Kwee LC; Thompson EJ; He M; Hornik CP; Devore AD; Patel CB; Mentz RJ; Fudim M; Taylor L; Milosovic S; Hurdle M; Cade WT; Ilkayeva O; Muehlbauer MJ; Newgard CB; Kelly DP; Zamani P; Margulies KB; Shah SH Metabolic and Pharmacokinetic Profiling of a Ketone Ester by Background SGLT2 Inhibitor Therapy in HFrEF , J Am Coll Cardiol Basic Trans Science, 10(3): 2025,290-303

Zamani P, Shah SJ, Cohen JB, Zhao M, Yang W, Afable JL, Caturla M, Maynard H, Pourmussa B, Demastus C, Mohanty I, Miyake MM, Adusumalli S, Margulies KB, Prenner SB, Poole DC, Wilson N, Reddy R, Townsend RR, Ischiropoulos H, Cappola TP, Chirinos JA Potassium Nitrate in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial , JAMA Cardiol., 10(3): 2025,284

Selvaraj S, Karaj A, Chirinos JA, Denney N, Fernando M, Chambers K, Demastus C, Langham M, Maynard H, Pourmussa B, Prenner SB, Cohen J, Ischiropoulos H, Rickels M, Church D, Wolfe R, Kelly DP, Putt ME, Margulies KB, Zamani P. FUEL UTILIZATION DURING EXERCISE WITH EXOGENOUS KETONES VERSUS PLACEBO IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: KETO-HFPEF , American College of Cardiology Annual Session, March 29-31, 2025; Chicago, IL.: 2025

Gan S; Azzo JD; Zhao L; Pourmussa B; Dib MJ; Salman O; Erten O; Ebert C; Richards AM; Javaheri A; Mann DL; Rietzschel E; Zamani P; van Empel V; Cappola TP, Chirinos JA Transferrin Saturation, Serum Iron, and Ferritin in Heart Failure: Prognostic Significance and Proteomic Associations. , Circ Heart Fail, 18(2): 2025,e011728

Selvaraj S, He C, Thompson E, Hornik CP, Devore AD, Patel CB, Mentz RJ, Fudim M, Kwee LC, Taylor L, Milosovic S, Hurdle M, Cade W, Ilkayeva O, Muehlbauer M, Newgard C, Kelly DP, Zamani P, Margulies KB, Shah SH Metabolic and Pharmacokinetic Profiling of Ketone Ester by Background SGLT2 Inhibitor Therapy in Heart Failure with Reduced Ejection: A Phase I Clinical Trial , American Heart Association Scientific Sessions: 2024

Salman O, Zamani P, Zhao L, Dib MJ, Gan S, Azzo JD, Pourmussa B, Richards AM, Javaheri A, Mann DL, Rietzschel E, Zhao M, Wang Z, Ebert C, Liu L, Gunawardhana KL, Greenawalt D, Carayannopoulos L, Chang CP, van Empel V, Gogain J, Schafer PH, Gordon DA, Ramirez-Valle F, Cappola TP, Chirinos JA Prognostic Significance and Biologic Associations of senescence-associated secretory phenotype (SASP) Biomarkers in Heart Failure (HF) , J Am Heart Assoc, 13(17): 2024,e033675

Selvaraj S, Chirinos JA, Putt M, Karaj A, Prenner SB, Cohen JA, Denney N, Gross G, Fernando M, Chambers K, Demastus C, Langham M, Kumar D, Maynard H, Poumussa B, Poole DC, Church DC, Wolfe RR, Margulies KB, Zamani P Effects Of Exogenous Ketone Therapy On Exercise Capacity In Heart Failure With Preserved Ejection Fraction: KETO-HFpEF , Heart Failure Society of America Annual Session: 2024